Abstract
Because of an increased emergence of resistance to current antitubercular drugs, there is a need for new antitubercular agents directed against novel targets. Diaminopimelic acid (DAP) biosynthetic enzymes are unique to bacteria and are absent in mammals and provide a rich source of essential targets for antitubercular chemotherapy. Herein, we review the structure and function of the mycobacterial DAP biosynthetic enzymes.
| Original language | English |
|---|---|
| Journal | FEMS Microbiology Letters |
| DOIs | |
| Publication status | Published - 16 Feb 2012 |